Neovasc Inc. Selling, General and Administrative (SG&A) Expenses Growth

Selling, General and Administrative (SG&A) Expenses Growth of NVCN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Selling, General and Administrative (SG&A) Expenses Growth growth rates and interactive chart.


Highlights and Quick Summary

  • Selling, General and Administrative (SG&A) Expenses Growth for the quarter ending March 31, 2022 was -35.55% (a -22.75% decrease compared to previous quarter)
  • Year-over-year quarterly Selling, General and Administrative (SG&A) Expenses Growth decreased by -195.21%
  • Annual Selling, General and Administrative (SG&A) Expenses Growth for 2021 was 8.44% (a -78.69% decrease from previous year)
  • Annual Selling, General and Administrative (SG&A) Expenses Growth for 2020 was 39.61% (a -214.91% decrease from previous year)
  • Annual Selling, General and Administrative (SG&A) Expenses Growth for 2019 was -34.47% (a -567.71% decrease from previous year)
  • Twelve month Selling, General and Administrative (SG&A) Expenses Growth ending March 31, 2022 was -18.9% (a -323.93% decrease compared to previous quarter)
  • Twelve month trailing Selling, General and Administrative (SG&A) Expenses Growth decreased by -132.11% year-over-year
Trailing Selling, General and Administrative (SG&A) Expenses Growth for the last four month:
31 Mar '22 31 Dec '21 30 Sep '21 30 Jun '21
-18.9% 8.44% 24.14% 58.86%
Visit stockrow.com/NVCN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Selling, General and Administrative (SG&A) Expenses Growth of Neovasc Inc.

Most recent Selling, General and Administrative (SG&A) Expenses Growthof NVCN including historical data for past 10 years.

Interactive Chart of Selling, General and Administrative (SG&A) Expenses Growth of Neovasc Inc.

Neovasc Inc. Selling, General and Administrative (SG&A) Expenses Growth for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -35.55%
2021 -46.02% -26.38% 37.34% 95.02% 8.44%
2020 20.26% 99.42% 49.69% -0.27% 39.61%
2019 -47.36% -60.6% 16.08% 10.64% -34.47%
2018 -29.38% 208.94% -0.63% -19.79% 7.37%
2017 228.03% -42.38% -67.44% -42.66% -16.64%
2016 -31.13% -21.29% 107.85% 144.56% 36.45%
2015 30.34% 73.61% -14.47% 142.59% 33.87%
2014 152.17% 177.32% 360.22% -41.62% 127.68%
2013 26.37% -1.02% -5.1% 38.4% 16.02%
2012 -20.87% 1.03% 5.38% -27.75% 24.1%
2011 -19.42%

Business Profile of Neovasc Inc.

Sector: Healthcare
Industry: Medical Devices
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.